HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marco Volante Selected Research

Adrenal Cortex Neoplasms (Adrenocortical Cancer)

12/2019Activity and safety of temozolomide in advanced adrenocortical carcinoma patients.
10/2017Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma.
1/2017Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer.
2/2015RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization.
5/2013Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates.
6/2012Ribonucleotide reductase large subunit (RRM1) gene expression may predict efficacy of adjuvant mitotane in adrenocortical cancer.
5/2010Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer.
12/2008Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marco Volante Research Topics

Disease

106Neoplasms (Cancer)
08/2022 - 01/2000
32Carcinoma (Carcinomatosis)
03/2022 - 10/2002
24Adrenocortical Carcinoma
05/2021 - 12/2006
14Carcinoid Tumor (Carcinoid)
01/2021 - 12/2010
10Adenocarcinoma
02/2021 - 08/2005
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 10/2006
8Adrenal Cortex Neoplasms (Adrenocortical Cancer)
12/2019 - 12/2008
7Neuroendocrine Carcinoma
09/2022 - 11/2009
7Lung Neoplasms (Lung Cancer)
06/2021 - 05/2009
7Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2021 - 11/2007
7Thyroid Neoplasms (Thyroid Cancer)
12/2020 - 01/2000
6Neoplasm Metastasis (Metastasis)
01/2021 - 10/2006
5Malignant Mesothelioma
01/2021 - 06/2014
5Disease Progression
12/2019 - 06/2008
5Prostatic Neoplasms (Prostate Cancer)
01/2019 - 06/2008
4Mesothelioma
08/2022 - 06/2014
4Adenoma (Adenomas)
05/2021 - 08/2005
4Necrosis
01/2021 - 12/2011
3Carcinogenesis
08/2021 - 01/2003
3Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 03/2007
3Adenocarcinoma of Lung
04/2020 - 06/2006
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2019 - 10/2006
3Parathyroid Neoplasms (Parathyroid Neoplasm)
01/2013 - 08/2005
2Pheochromocytoma
06/2022 - 06/2015
2Papillary Carcinoma
01/2022 - 10/2002
2Papillary Thyroid Cancer
01/2022 - 04/2003
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 08/2009
2Lymphatic Metastasis
01/2022 - 01/2015
2Adrenal Insufficiency (Adrenal Gland Hypofunction)
09/2021 - 10/2017
2Genetic Predisposition to Disease (Genetic Predisposition)
05/2021 - 08/2006
2Cushing Syndrome
11/2019 - 04/2014
2Small Cell Carcinoma
09/2019 - 12/2010
2Paraganglioma (Paragangliomas)
01/2017 - 06/2015
2Infections
04/2016 - 10/2012
2Adrenal Gland Neoplasms (Adrenal Cancer)
02/2015 - 01/2014
2Hypoxia (Hypoxemia)
08/2014 - 11/2005
2Starvation
07/2014 - 07/2009
2Breast Neoplasms (Breast Cancer)
01/2014 - 10/2010
2Inflammation (Inflammations)
08/2012 - 08/2010

Drug/Important Bio-Agent (IBA)

27Proteins (Proteins, Gene)FDA Link
08/2022 - 10/2002
19Biomarkers (Surrogate Marker)IBA
06/2022 - 03/2014
13Mitotane (Lysodren)FDA Link
01/2020 - 12/2008
11Messenger RNA (mRNA)IBA
11/2019 - 03/2002
11Biological ProductsIBA
01/2019 - 04/2002
9Thymidylate SynthaseIBA
08/2022 - 10/2006
8DNA (Deoxyribonucleic Acid)IBA
04/2020 - 09/2004
7MicroRNAs (MicroRNA)IBA
08/2022 - 08/2014
7Hormones (Hormone)IBA
09/2021 - 03/2002
7Pharmaceutical PreparationsIBA
08/2021 - 05/2015
7ParaffinIBA
05/2021 - 10/2002
7Galectin 3 (LGALS3)IBA
06/2008 - 10/2002
6AndrogensIBA
01/2019 - 06/2008
6ErbB Receptors (EGF Receptor)IBA
12/2017 - 03/2007
6GhrelinIBA
01/2013 - 03/2002
5Tyrosine Kinase InhibitorsIBA
12/2018 - 09/2007
5Formaldehyde (Formol)FDA Link
03/2015 - 01/2003
4Reticulin (Reticular Fiber)IBA
03/2022 - 12/2011
4Somatostatin Receptors (Somatostatin Receptor)IBA
01/2020 - 01/2003
4AntibodiesIBA
11/2019 - 06/2007
4Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2018 - 11/2007
4MucinsIBA
01/2017 - 09/2007
4Chromogranin AIBA
11/2010 - 08/2005
3Transcription Factors (Transcription Factor)IBA
09/2022 - 07/2013
3Histones (Histone)IBA
03/2021 - 09/2014
3prolinedithiocarbamate (PDTC)IBA
12/2020 - 03/2010
3somatostatin receptor 2IBA
01/2020 - 01/2018
3EnzymesIBA
01/2020 - 08/2006
3RNA (Ribonucleic Acid)IBA
12/2019 - 06/2008
3Phosphotransferases (Kinase)IBA
12/2018 - 12/2013
3TOR Serine-Threonine KinasesIBA
06/2018 - 12/2010
3SteroidsIBA
10/2017 - 10/2013
3Caveolin 1IBA
12/2016 - 07/2009
3Coloring Agents (Dyes)IBA
09/2013 - 06/2007
3Fluorouracil (Carac)FDA LinkGeneric
06/2010 - 02/2008
2AsbestosIBA
05/2021 - 09/2019
2Cisplatin (Platino)FDA LinkGeneric
04/2021 - 11/2009
2xylometazoline (stas)IBA
01/2021 - 09/2019
2LipidsIBA
01/2021 - 01/2013
2Peptide Receptors (Peptide Receptor)IBA
01/2020 - 01/2003
2MTOR InhibitorsIBA
06/2018 - 12/2010
2Mechanistic Target of Rapamycin Complex 1IBA
06/2018 - 01/2017
2Glucose (Dextrose)FDA LinkGeneric
01/2018 - 08/2012
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 05/2015
2Monoclonal AntibodiesIBA
01/2018 - 04/2003
2Mitochondrial DNA (mtDNA)IBA
11/2017 - 12/2011
2Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2017 - 01/2003
2NucleotidesIBA
01/2017 - 03/2013
2Matrix Metalloproteinases (MMPs)IBA
12/2016 - 12/2006
2Antiviral Agents (Antivirals)IBA
04/2016 - 10/2012
2Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
01/2015 - 06/2012
2Steroidogenic Factor 1IBA
08/2014 - 05/2013
2Octreotide (Sandostatin)FDA LinkGeneric
03/2014 - 11/2009
2Capecitabine (Xeloda)FDA Link
03/2014 - 06/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2014 - 10/2010
2GemcitabineFDA Link
01/2014 - 06/2010
2Cytotoxins (Cytolysins)IBA
01/2014 - 05/2009
2Peptides (Polypeptides)IBA
07/2012 - 01/2003
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2011 - 11/2009

Therapy/Procedure

23Therapeutics
06/2021 - 01/2003
10Drug Therapy (Chemotherapy)
08/2022 - 02/2009